phosphoGigolo statistics

To access cutting-edge analytics on consensus tools, life science contexts and associated fields, you will need to subscribe to our premium service.


Citations per year

Citations chart

Popular tool citations

chevron_left Phosphorylation site assignment chevron_right
Popular tools chart

Tool usage distribution map

Tool usage distribution map

Associated diseases

Associated diseases

phosphoGigolo specifications


Unique identifier OMICS_19550
Name phosphoGigolo
Software type Application/Script
Interface Command line interface, Graphical user interface
Restrictions to use None
Input data A set pepXML formatted MS2 /MS3 level search results.
Input format TSV
Operating system Windows
Programming languages C++
Computer skills Advanced
Version 4.3.1
Stability Stable
Maintained Yes



Add your version


  • person_outline Andy Tao <>

Publication for phosphoGigolo

phosphoGigolo in publication

PMCID: 2063582
PMID: 17940529
DOI: 10.1038/msb4100182

[…] of a phosphopeptide, namely that the amino-acid sequence is identical but that the site of phosphorylation is different. after consolidation of the phosphopeptides using the computer program ‘phosphogigolo' (), we computed for a given dcn value the percentage of peptides that have the same amino-acid sequence (ignoring the phosphate group and the fact that a peptide can exist in two […]

To access a full list of publications, you will need to upgrade to our premium service.

phosphoGigolo institution(s)
Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland; Institute for Systems Biology, Seattle, WA, USA; Faculty of Science, University of Zurich, Switzerland; Laboratoire Analyse et Modélisation pour la Biologie et l’Environnement (LAMBE), Evry, France; Department of Biochemistry, Purdue University, West Lafayette, IN, USA
phosphoGigolo funding source(s)
Supported by Purdue University, Federal funds from the National Heart, Lung, Blood Institute, National Institutes of Health, under contract No. N01-HV-28179, and by a fellowship from the Boehringer Ingelheim Fonds.

phosphoGigolo reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review phosphoGigolo